ResMed (RMD) PT Lifted to $57 on Solid Q1

Go back to ResMed (RMD) PT Lifted to $57 on Solid Q1

William Blair Upgrades ResMed (RMD) to Outperform

October 24, 2014 7:09 AM EDT

William Blair upgraded ResMed (NYSE: RMD) from Market Perform to Outperform.

For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.

Shares of ResMed closed at $47.70 yesterday.

... More

ResMed (RMD) Reports In-Line Q1 EPS

October 23, 2014 4:20 PM EDT

ResMed (NYSE: RMD) reported Q1 EPS of $0.58, in-line with the analyst estimate of $0.58. Revenue for the quarter came in at $380.4 million versus the consensus estimate of $375 million.

For earnings history and earnings-related data on ResMed (RMD) click here.

... More